{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:32:29Z","timestamp":1793514749805,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["GPP 2022"],"award-info":[{"award-number":["GPP 2022"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinthera.2025.10.011","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:33:00Z","timestamp":1764826380000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a Spacer"],"prefix":"10.1016","volume":"48","author":[{"given":"Hitesh","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Bednarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Kokot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Heijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Petullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Jassal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2025.10.011_bib0001","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/17476348.2014.905916","article-title":"Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence","volume":"8","author":"Aggarwal","year":"2014","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02106-2021","article-title":"The environmental impact of inhaled therapy: making informed treatment choices","volume":"60","author":"Woodcock","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0003","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.2147\/DDDT.S262141","article-title":"The climate is changing for metered-dose inhalers and action is needed","volume":"14","author":"Pritchard","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2023.102245","article-title":"Relative bioavailability of budesonide\/glycopyrrolate\/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential","volume":"83","author":"Aurivillius","year":"2023","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0005","first-page":"A38","article-title":"S60 A new medical propellant HFO-1234ze(E): reducing the environmental impact of inhaled medicines","volume":"77","author":"Hargreaves","year":"2022","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.clinthera.2025.10.011_bib0006","first-page":"275","article-title":"A randomized, double-blind crossover study of change in post-dose lung function with hydrofluoroolefin-1234ze, a next-generation propellant for metered dose inhalers, in participants with asthma","volume":"38","author":"Pleasants","year":"2025","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0007","first-page":"A1216","article-title":"Lung exposure bioequivalence with budesonide\/glycopyrrolate\/formoterol fumarate with the next generation propellant hydrofluoroolefin-1234ze versus hydrofluoroalkane-134a in healthy adults: a charcoal block study [abstract]","volume":"209","author":"Raphiou","year":"2024","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0008","first-page":"A3824","article-title":"Systemic exposure bioequivalence of budesonide\/glycopyrrolate\/formoterol fumarate with the potential next generation propellant hydrofluoroolefin-1234ze versus hydrofluoroalkane-134a in healthy adults [abstract]","volume":"209","author":"Shah","year":"2024","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0009","doi-asserted-by":"crossref","first-page":"103402","DOI":"10.1016\/j.eclinm.2025.103402","article-title":"Safety of budesonide\/glycopyrronium\/formoterol fumarate dihydrate delivered by HFO-1234ze versus HFA-134a in chronic obstructive pulmonary disease: a phase 3, multi-site, randomised, double-blind, parallel-group, active-comparator study","volume":"87","author":"Usmani","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0010","doi-asserted-by":"crossref","first-page":"00065","DOI":"10.1183\/23120541.00065-2018","article-title":"Spacer devices for inhaled therapy: why use them, and how?","volume":"4","author":"Vincken","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0011","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cpdd.585","volume":"8","author":"Maes","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0012","unstructured":"European Medicines Agency. Guideline on the requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-requirements-demonstrating-therapeutic-equivalence-between-orally-inhaled-products-oip-asthma-chronic-obstructive-pulmonary-disease-copd-revision-2_en.pdf, 2025. Accessed August 14, 2025."},{"key":"10.1016\/j.clinthera.2025.10.011_bib0013","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.clinthera.2020.02.012","article-title":"Relative bioavailability of budesonide\/glycopyrrolate\/formoterol fumarate metered dose inhaler administered with and without a spacer: results of a phase I, randomized, crossover trial in healthy adults","volume":"42","author":"Dorinsky","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0014","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41533-017-0022-1","article-title":"Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review","volume":"27","author":"Klijn","year":"2017","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12931-017-0710-y","article-title":"Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes","volume":"19","author":"Usmani","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0016","unstructured":"European Medicines Agency, Trixeo Aerosphere\u2122 summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/trixeo-aerosphere-epar-product-information_en.pdf, 2021. Accessed July 9, 2025."},{"key":"10.1016\/j.clinthera.2025.10.011_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059929","article-title":"Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial","volume":"12","author":"Dierick","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.clinthera.2025.10.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2023-001716","article-title":"Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis","volume":"10","author":"Gagn\u00e9","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0019","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2147\/COPD.S416988","article-title":"Estimating the health and economic impact of improved management in prevalent chronic obstructive pulmonary disease populations in England, Germany, Canada, and Japan: a modelling study","volume":"18","author":"Adams","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.clinthera.2025.10.011_bib0020","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.7326\/M22-1460","article-title":"Good Publication Practice (GPP) guidelines for company-sponsored biomedical research: 2022 update","volume":"175","author":"DeTora","year":"2022","journal-title":"Ann Intern Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825003789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825003789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:22:31Z","timestamp":1777490551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825003789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0149291825003789"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.10.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a Spacer","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}